» Articles » PMID: 24741510

Type 1 Diabetes and Osteoporosis: A Review of Literature

Overview
Specialty Endocrinology
Date 2014 Apr 18
PMID 24741510
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

With better care and intensive insulin therapy, microvascular complications have reduced and longevity has increased in patients with type 1 diabetes (T1DM). Therefore, there is a need to change the focus from microvascular complications to cardiovascular disease and osteoporosis. Though number of studies from other parts of the world show that patients with T1DM are at increased risk of osteoporosis and fractures, there is a paucity of data from India. A number of factors and mechanisms affecting bone health in patients with T1DM have been proposed. The main defect in genesis of osteoporosis is osteoblastic function, rather than osteoclastic overfunction. Assessment of bone mineral density by dual X-ray absorptiometry and other risk factors for osteoporosis, as a part of diagnostic procedure can help to design tailored treatment plans. A physically active healthy lifestyle, prevention of diabetic complications and adequate calcium and vitamin D supplementation are the mainstay for prevention of osteoporosis. Treatment of osteoporosis is not evidence based but it is proposed to be similar to osteoporosis associated with other conditions. Bisphosphonates are the mainstay for treatment of osteoporosis in patients with T1DM. However, more studies are needed to make definitive guidelines on prevention and treatment of osteoporosis in patients with T1DM.

Citing Articles

Bone Loss in Diabetes Mellitus: Diaporosis.

Kupai K, Kang H, Posa A, Csonka A, Varkonyi T, Valkusz Z Int J Mol Sci. 2024; 25(13).

PMID: 39000376 PMC: 11242219. DOI: 10.3390/ijms25137269.


Alkaline Water Mitigates Bone Loss in Streptozotocin-Induced Type II Diabetic Rats.

Alghamdi B Cureus. 2024; 16(5):e59833.

PMID: 38846188 PMC: 11156442. DOI: 10.7759/cureus.59833.


Type 1 diabetes human enteroid studies reveal major changes in the intestinal epithelial compartment.

Bharadiya V, Rong Y, Zhang Z, Lin R, Guerrerio A, Tse C Sci Rep. 2024; 14(1):11911.

PMID: 38789719 PMC: 11126659. DOI: 10.1038/s41598-024-62282-x.


Vitamin D and Insulin-Dependent Diabetes: A Systematic Review of Clinical Trials.

Dadon Y, Hecht Sagie L, Mimouni F, Arad I, Mendlovic J Nutrients. 2024; 16(7).

PMID: 38613075 PMC: 11013464. DOI: 10.3390/nu16071042.


Bone Mineral Density Evaluation Among Type 2 Diabetic Patients in Rural Haryana, India: An Analytical Cross-Sectional Study.

Khandelwal N, Rajauria S, Kanjalkar S, Chavanke O, Rai S Cureus. 2023; 15(9):e45908.

PMID: 37885541 PMC: 10599097. DOI: 10.7759/cureus.45908.


References
1.
Moerman E, Teng K, Lipschitz D, Lecka-Czernik B . Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell. 2004; 3(6):379-89. PMC: 1850101. DOI: 10.1111/j.1474-9728.2004.00127.x. View

2.
Lu H, Kraut D, Gerstenfeld L, Graves D . Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation. Endocrinology. 2002; 144(1):346-52. DOI: 10.1210/en.2002-220072. View

3.
Kota S, Meher L, Jammula S, Kota S, Modi K . Clinical profile of coexisting conditions in type 1 diabetes mellitus patients. Diabetes Metab Syndr. 2012; 6(2):70-6. DOI: 10.1016/j.dsx.2012.08.006. View

4.
Nixon A, Lillich J, Burton-Wurster N, Lust G, Mohammed H . Differentiated cellular function in fetal chondrocytes cultured with insulin-like growth factor-I and transforming growth factor-beta. J Orthop Res. 1998; 16(5):531-41. DOI: 10.1002/jor.1100160503. View

5.
Munoz-Torres M, Jodar E, Escobar-Jimenez F, Luna J . Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus. Calcif Tissue Int. 1996; 58(5):316-9. DOI: 10.1007/BF02509378. View